MRK - Company ID 0000310158
Merck & Co., Inc. (MRK) reported revenue of $65.01B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $65.01B | +1.3% |
| FY 2024 | $64.17B | +6.7% |
| FY 2023 | $60.12B | +1.4% |
| FY 2022 | $59.28B | +21.7% |
| FY 2021 | $48.70B | +17.3% |
| FY 2020 | $41.52B | +6.1% |
| FY 2019 | $39.12B | -7.5% |
| FY 2018 | $42.29B | +5.4% |
| FY 2017 |
Merck & Co., Inc. (MRK) reported revenue of $65.01B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2007 and fiscal 2025, Merck & Co., Inc.'s revenue grew from $24.20B to $65.01B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $40.12B |
| +0.8% |
| FY 2016 | $39.81B | -13.4% |
| FY 2010 | $45.99B | +67.7% |
| FY 2009 | $27.43B | +15.0% |
| FY 2008 | $23.85B | -1.4% |
| FY 2007 | $24.20B | - |